Form 8-K · Current report
Nordson Corporation 8-K, filed Aug 19, 2026
- Filed
- CIK
- 0000072331
- Accession no.
- 0000072331-26-000052
Summary
Nordson Corporation reported record third-quarter fiscal 2026 results, with sales of $818 million (up 10% year over year) and diluted earnings per share of $2.73 (up 23%), and increased its full-year guidance to sales of $3,035–$3,075 million and adjusted earnings of $11.80–$12.00 per diluted share. CEO Sundaram Nagarajan attributed the results to demand momentum, the Ascend Strategy and order entry, with backlog up 35% over the prior year.
Key points
- Third-quarter sales of $818 million rose 10% year over year, including about 12% organic growth.
- Net income was $153 million, or $2.73 per diluted share; adjusted diluted earnings per share were $3.25, up 19%.
- Sales rose in all three segments: Industrial Precision Solutions $367 million, Medical and Fluid Solutions $231 million, and Advanced Technology Solutions $220 million, up 28%.
- Backlog was up 35% compared with the prior year, and management will discuss results and outlook on a webcast on August 20, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On August 19, 2026, Nordson Corporation issued a press release relating to its results of operations for the third quarter of fiscal 2026. A copy is attached as Exhibit 99.1. Item 7.01. Regulation FD Disclosure. Nordson Corporation will provide additional commentary on third quarter fiscal 2026 results and outlook during a webcast on Thursday, August 20, 2026 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available after the event. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.